Pam will talk about her experience developing Ozmosis Research, a social enterprise clinical trials management company. She will also discuss what inspired Amit Oza to create Ozmosis Research and how they made their vision come to life.
Ms. Degendorfer is Chief Operating Officer at Ozmosis Research, a social enterprise company that manages oncology clinical trials both nationally and internationally. She has been actively involved in all aspects of the organization including business development and clinical operations. Profits from Ozmosis Research may be directed by the Board towards oncology clinical research at the Princess Margaret. Ms. Degendorfer is also the Program Director for the Cancer Clinical Research Unit (CCRU) at the Princess Margaret Cancer Centre. After graduating with a Master’s Degree from the University of Toronto, Ms. Degendorfer began her career at Princess Margaret in the Biostatistics Department. She was recruited to the Drug Development Program in 2001 where she was appointed Manager of the Robert & Maggie Bras and Family New Drug Development Program helping build the program into the largest cancer drug development program in Canada.
In 2009 she became Program Director of CCRU. She completed the University Health Network- Rotman Leadership Development Program. Ms. Degendorfer was a member of the University Health Network Oncology Research Ethics Board and has been a certified member of the Society of Clinical Research Professionals since 2001 and is a member of DIA.
She has been an expert consultant for academic cancer centres in Canada and abroad. Working with a variety of sponsors including pharmaceutical companies, biotechnology companies and the National Cancer Institute in both the United States and Canada has given Ms. Degendorfer a wide breadth of experience in clinical trials management.